Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now
Quote Panel
Key Metrics
Fundamentals
Relative Strength
THYROCARE.NS
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
|---|---|---|---|
Forecast
Analyst rating
Last analyst upgrade/downgrade
Earnings Growth
YoY
Current
Estimates
Q2.23
N/A
3.27
vs NA
Q3.23
N/A
3.84
vs NA
Q4.23
+26%
2.36
vs 1.88
Q1.24
N/A
NA
vs 2.36
Q2.24
+17%
3.84
vs 3.27
Q3.24
-28%
2.77
vs 3.84
Q4.24
+50%
3.54
vs 2.36
Q1.25
N/A
NA
vs NA
Q2.25
+17%
4.5
vs 3.84
Q3.25
+84%
5.1
vs 2.77
Sales Growth
YoY
Current
Estimates
Q2.23
+6%
1.3B vs 1.3B
Q3.23
+10%
1.5B vs 1.3B
Q4.23
+5%
1.3B vs 1.3B
Q1.24
+14%
1.5B vs 1.4B
Q2.24
+16%
1.6B vs 1.3B
Q3.24
+20%
1.8B vs 1.5B
Q4.24
+23%
1.7B vs 1.3B
Q1.25
+21%
1.9B vs 1.5B
Q2.25
-2%
1.5B vs 1.6B
Q3.25
-2%
1.7B vs 1.8B
Return on Equity
QoQ
Q2.23
+3%
0.03
vs 0.02
Q3.23
+4%
0.04
vs 0.03
Q4.23
+3%
0.03
vs 0.04
Q1.24
+3%
0.03
vs 0.03
Q2.24
+5%
0.05
vs 0.03
Q3.24
+5%
0.05
vs 0.05
Q4.24
+4%
0.04
vs 0.05
Q1.25
+4%
0.04
vs 0.04
Institutionnal Ownership
QoQ
Q4.17
1
1
vs NA
NA
Q1.18
1
1
vs 1
NA
Q2.18
1
1
vs 1
NA
Relative Strength
THYROCARE.NS
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
|---|---|---|---|
Forecast
266%2026-Revenue
329%2026-EPS
415%2026-EBITDA
Analyst rating
Strong Sell
Sell
Buy
Neutral
Strong Buy
Price Target
NaN(-100.00%)
Number of analyst
Last analyst upgrade/downgrade
No Data Available
Quote Panel
Key Metrics
Thyrocare Technologies Limited provides diagnostic testing services to patients, laboratories, and hospitals in India. It operates in three segments: Diagnostic Testing Services, Imaging Services, and Others. The company conducts various medical diagnostic tests and profiles of tests that focuses on early detection and management of disorders and diseases, including thyroid, growth, metabolism, auto-immunity, diabetes, anaemia, cardiovascular, infertility, COVID, and various infectious diseases. Its profiles of tests include 34 profiles of tests administered under its Aarogyam brand, which offers patients a suite of wellness and preventive health care tests. The company also sells glucometer and glucostrips under the brand name Sugarscan; consumables; and radiopharmaceutical. Thyrocare Technologies Limited was founded in 1996 and is based in Navi Mumbai, India. Thyrocare Technologies Limited is a subsidiary of Docon Technologies Private Limited.
NSE
23.30Â ( 2.45%)
After-hours NaN$0.00 (0.00%)
Relative Strenght
Volume Buzz
-53%
Earning Acce
No
Dist 52w H.
9%Fundamentals
P/E Ratio
P/S Ratio
P/B Ratio
Debt/Equity
Net Margin
EPS
How THYROCARE.NS compares to sector?